These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


422 related items for PubMed ID: 26351870

  • 1. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
    Landi A, Gregori F, Marotta N, Delfini R.
    J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
    [Abstract] [Full Text] [Related]

  • 2. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
    Hutchinson RW, Werrlein S, Johns DB, Zhang G, Clymer JW, Kocharian R.
    Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
    [Abstract] [Full Text] [Related]

  • 3. Use of floseal hemostatic matrix for control of hemostasis during laparoscopic cholecystectomy for acute cholecystitis: a multicenter historical control group comparison (the GLA study gelatin matrix for acute cholecystitis).
    Sartelli M, Catena F, Biancafarina A, Tranà C, Piccardo A, Ceccarelli G, Tirone G, Agresta F, Di Giorgio A, Catani M, Tricarico F, Buonanno M, Piazza L.
    J Laparoendosc Adv Surg Tech A; 2014 Dec; 24(12):837-41. PubMed ID: 25025393
    [Abstract] [Full Text] [Related]

  • 4. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA, Cruz RM.
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [Abstract] [Full Text] [Related]

  • 5. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
    David G, Lim S, Gunnarsson C, Kocharian R, Roy S.
    J Med Econ; 2015 Nov; 18(9):735-45. PubMed ID: 25907200
    [Abstract] [Full Text] [Related]

  • 6. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
    Nasso G, Piancone F, Bonifazi R, Romano V, Visicchio G, De Filippo CM, Impiombato B, Fiore F, Bartolomucci F, Alessandrini F, Speziale G.
    Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
    [Abstract] [Full Text] [Related]

  • 7. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
    Makhija D, Rock M, Ikeme S, Kuntze E, Epstein JD, Nicholson G, Price JS, Patel V.
    J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
    [Abstract] [Full Text] [Related]

  • 8. Commentary on: Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal vs Surgiflo.
    Gazzeri R.
    J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):143-5. PubMed ID: 26839111
    [No Abstract] [Full Text] [Related]

  • 9. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
    Price JS, Tackett S, Patel V.
    J Med Econ; 2015 Mar; 18(10):777-86. PubMed ID: 25934148
    [Abstract] [Full Text] [Related]

  • 10. Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.
    Ma L, Dai L, Yang Y, Liu H.
    Medicine (Baltimore); 2018 Dec; 97(49):e13511. PubMed ID: 30544449
    [Abstract] [Full Text] [Related]

  • 11. Epidural spinal cord compression with neurologic deficit associated with intrapedicular application of hemostatic gelatin matrix during pedicle screw insertion.
    Buchowski JM, Bridwell KH, Lenke LG, Good CR.
    Spine (Phila Pa 1976); 2009 Jun 01; 34(13):E473-7. PubMed ID: 19478651
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of a Thrombin-Containing Collagen-Based Hemostatic Agent in Spinal Surgery: A Randomized Clinical Trial.
    Park SM, Kang DR, Lee JH, Jeong YH, Shin DA, Yi S, Ha Y, Kim KN.
    World Neurosurg; 2021 Oct 01; 154():e215-e221. PubMed ID: 34246825
    [Abstract] [Full Text] [Related]

  • 13. Real-world outcomes of hemostatic matrices in cardiac surgery.
    Tackett SM, Calcaterra D, Magee G, Lattouf OM.
    J Cardiothorac Vasc Anesth; 2014 Dec 01; 28(6):1558-65. PubMed ID: 25245578
    [Abstract] [Full Text] [Related]

  • 14. Is the use of hemostatic matrix (Floseal) and alkylene oxide copolymer (Ostene) safe in spinal laminectomies? Peridural fibrosis assessment.
    Gurcan O, Gurcay AG, Kazanci A, Onder E, Senturk S, Bavbek M.
    Acta Orthop Traumatol Turc; 2017 Mar 01; 51(2):165-168. PubMed ID: 28246047
    [Abstract] [Full Text] [Related]

  • 15. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery.
    Danker W, Kelkar SS, Marston XL, Aggarwal J, Johnston SS.
    J Comp Eff Res; 2022 Dec 01; 11(17):1231-1240. PubMed ID: 36306241
    [Abstract] [Full Text] [Related]

  • 16. Control of major pulmonary artery bleeding with a gelatin matrix-thrombin solution: a retrospective analysis.
    Cardillo G, Carleo F, DI Martino M, Ciamberlano B, Ialongo P, Cusumano G, Denitza Tinti M, Ricci A, Cafarotti S.
    J Cardiovasc Surg (Torino); 2017 Dec 01; 58(6):904-908. PubMed ID: 26337014
    [Abstract] [Full Text] [Related]

  • 17. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
    Makhija D, Rock M, Xiong Y, Epstein JD, Arnold MR, Lattouf OM, Calcaterra D.
    J Med Econ; 2017 Jun 01; 20(6):565-573. PubMed ID: 28097913
    [Abstract] [Full Text] [Related]

  • 18. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
    Woodworth BA, Chandra RK, LeBenger JD, Ilie B, Schlosser RJ.
    Am J Otolaryngol; 2009 Jun 01; 30(1):49-53. PubMed ID: 19027513
    [Abstract] [Full Text] [Related]

  • 19. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
    Gazzeri R, Galarza M, Alfier A.
    Surg Technol Int; 2012 Dec 01; 22():49-54. PubMed ID: 22915500
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative anaphylaxis secondary to intraosseous gelatin administration.
    Luhmann SJ, Sucato DJ, Bacharier L, Ellis A, Woerz C.
    J Pediatr Orthop; 2013 Dec 01; 33(5):e58-60. PubMed ID: 23752162
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.